Free Trial

Bausch + Lomb (BLCO) Competitors

$15.34
-0.05 (-0.32%)
(As of 05/31/2024 ET)

BLCO vs. COO, RXST, STAA, WRBY, EYE, LUCY, ALC, ALGN, TEVA, and ALNY

Should you be buying Bausch + Lomb stock or one of its competitors? The main competitors of Bausch + Lomb include Cooper Companies (COO), RxSight (RXST), STAAR Surgical (STAA), Warby Parker (WRBY), National Vision (EYE), Innovative Eyewear (LUCY), Alcon (ALC), Align Technology (ALGN), Teva Pharmaceutical Industries (TEVA), and Alnylam Pharmaceuticals (ALNY). These companies are all part of the "medical" sector.

Bausch + Lomb vs.

Cooper Companies (NASDAQ:COO) and Bausch + Lomb (NYSE:BLCO) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, community ranking, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

Cooper Companies has a net margin of 9.11% compared to Cooper Companies' net margin of -7.81%. Bausch + Lomb's return on equity of 8.94% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies9.11% 8.94% 5.75%
Bausch + Lomb -7.81%3.60%1.94%

Cooper Companies received 585 more outperform votes than Bausch + Lomb when rated by MarketBeat users. Likewise, 66.56% of users gave Cooper Companies an outperform vote while only 38.71% of users gave Bausch + Lomb an outperform vote.

CompanyUnderperformOutperform
Cooper CompaniesOutperform Votes
609
66.56%
Underperform Votes
306
33.44%
Bausch + LombOutperform Votes
24
38.71%
Underperform Votes
38
61.29%

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are owned by institutional investors. 2.0% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Cooper Companies currently has a consensus price target of $111.42, indicating a potential upside of 18.14%. Bausch + Lomb has a consensus price target of $19.45, indicating a potential upside of 26.82%. Given Cooper Companies' higher probable upside, analysts clearly believe Bausch + Lomb is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
Bausch + Lomb
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55

In the previous week, Cooper Companies had 18 more articles in the media than Bausch + Lomb. MarketBeat recorded 24 mentions for Cooper Companies and 6 mentions for Bausch + Lomb. Cooper Companies' average media sentiment score of 0.76 beat Bausch + Lomb's score of 0.67 indicating that Bausch + Lomb is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
6 Very Positive mention(s)
4 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Bausch + Lomb
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Bausch + Lomb has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500.

Cooper Companies has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$3.59B5.22$294.20M$1.7055.40
Bausch + Lomb$4.15B1.30-$260M-$0.96-15.98

Summary

Cooper Companies beats Bausch + Lomb on 15 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLCO vs. The Competition

MetricBausch + LombOphthalmic goods IndustryMedical SectorNYSE Exchange
Market Cap$5.39B$11.37B$5.13B$17.79B
Dividend YieldN/A1.63%2.75%3.55%
P/E Ratio-15.9851.19167.1725.81
Price / Sales1.306.872,418.7811.40
Price / Cash8.0620.3535.3018.95
Price / Book0.804.425.535.90
Net Income-$260M$224.33M$106.01M$976.46M
7 Day Performance2.13%-1.28%1.14%0.62%
1 Month Performance11.64%42.90%1.43%4.79%
1 Year Performance-15.90%6.38%4.07%24.00%

Bausch + Lomb Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
3.258 of 5 stars
$90.96
-0.2%
$109.69
+20.6%
+0.8%$18.08B$3.67B62.1915,000Earnings Report
Analyst Forecast
Short Interest ↑
News Coverage
Gap Up
RXST
RxSight
2.6142 of 5 stars
$60.79
+0.7%
$60.63
-0.3%
+123.4%$2.25B$89.08M-48.25374Positive News
STAA
STAAR Surgical
4.4814 of 5 stars
$40.70
+1.4%
$47.13
+15.8%
-28.1%$2.00B$326.24M131.291,115Positive News
WRBY
Warby Parker
0.5535 of 5 stars
$17.31
+3.2%
$16.50
-4.7%
+56.9%$1.72B$669.77M-36.833,491
EYE
National Vision
3.998 of 5 stars
$14.75
+4.1%
$19.60
+32.9%
-41.3%$1.16B$2.13B-16.0313,998Gap Up
LUCY
Innovative Eyewear
0.8639 of 5 stars
$0.90
-5.6%
$1.00
+11.6%
-51.7%$15.68M$1.15M0.0011Short Interest ↑
Gap Up
High Trading Volume
ALC
Alcon
1.6599 of 5 stars
$88.63
+1.4%
$94.71
+6.9%
+13.4%$43.70B$9.46B42.0025,000Short Interest ↑
ALGN
Align Technology
4.9407 of 5 stars
$258.40
+2.2%
$353.00
+36.6%
-13.5%$19.45B$3.86B42.5721,610Short Interest ↑
Positive News
TEVA
Teva Pharmaceutical Industries
1.0661 of 5 stars
$16.72
+1.6%
$14.75
-11.8%
+135.3%$18.74B$15.85B-40.7837,851Analyst Forecast
Analyst Revision
News Coverage
ALNY
Alnylam Pharmaceuticals
4.6968 of 5 stars
$147.60
+0.5%
$216.19
+46.5%
-21.3%$18.67B$1.83B-55.072,100Insider Selling

Related Companies and Tools

This page (NYSE:BLCO) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners